Lipoprotein Lipase anticorps

N° du produit ABIN966491

Détail du produit anti-Lipoprotein Lipase anticorps

Antigène: Lipoprotein Lipase (LPL)

Reactivité: Humain, Boeuf (Vache)

Hôte: Veuillez nous consulter SVP

Clonalité: Monoclonal

Conjugué: Cet anticorp Lipoprotein Lipase est non-conjugé

Application: Western Blotting (WB), ELISA

Specificité: Human LPL whole protein. Recognizes specifically LPL from human and bovine.

Isotype: IgG1

Information d'application

Indications d'application: Western blot (1:1000) and ELISA (1:2000~5000) in lipid metabolic research.

Restrictions: For Research Use only

Stockage

Concentration: 1mg/ml

Buffer: PBS, pH 7.4

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Détails sur Lipoprotein Lipase

Antigène: Lipoprotein Lipase (LPL)

Autre désignation: LPL (LPL Produits)

Synonymes: anticorps HDLCQ11, anticorps LIPD, anticorps fb62e04, anticorps fc49b03, anticorps wu:fb62e04, anticorps wu:fc49b03, anticorps LPL, anticorps lipd, anticorps hdlcq11, anticorps lpl, anticorps LOC100223817, anticorps lipoprotein lipase, anticorps LPL, anticorps Lpl, anticorps lpl

Sujet: Lipoprotein lipase (LPL) is the central enzyme in plasma triglyceride hydrolysis and is secreted by macrophages in the subendothelial space. Evidence has been provided that LPL produced by macrophages in the vessel wall exerts proatherogenic effects. The atherogenic effects of LPL have been mainly attributed to its ability to favor lipid accumulation within macrophages present in the atherosclerotic lesion. Recently, it has also been shown that LPL promote the development of atherosclerosis through facilitation of monocyte adhesion to endothelial cells, stimulation of tumor necrosis factor alpha (TNF ) secretion and induction of vascular smooth muscle cell proliferation.

ID gène: 4023

Pathways: Lipid Metabolism